Length of trials aside, the point I was making was not to expect the sp to do much here. If the sp of other companies can’t increase on great clinical results bcos of the market, why will this increase when announcing they are dosing patients??
- Forums
- ASX - By Stock
- ILA - Media coverage
ILA
island pharmaceuticals limited
Add to My Watchlist
3.23%
!
15.0¢

Length of trials aside, the point I was making was not to expect...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $35.41M |
Open | High | Low | Value | Volume |
15.0¢ | 15.0¢ | 13.5¢ | $112.6K | 779.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50771 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 6500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50771 | 0.150 |
1 | 85000 | 0.145 |
1 | 97440 | 0.140 |
2 | 11979 | 0.135 |
3 | 18192 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 6500 | 2 |
0.160 | 77965 | 4 |
0.165 | 74864 | 2 |
0.170 | 126954 | 3 |
0.175 | 40000 | 1 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
ILA (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online